Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02297906 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of Intranasal Ketorolac in Children
A Phase 1 study, sponsored by Columbia University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT02297906 is a Phase 1 study that was terminated before completion, run by Columbia University. The registered enrollment target is 18 participants.
The verdict
NCT02297906, a Phase 1 study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that is typically given to both adults and children by the intravenous (IV) or intramuscular (IM) route for analgesic purposes. Ketorolac can also be given by the intranasal (IN) route using a mucosal atomization device (MAD). We aim to study the pharmacokinetics of ketorolac when administered by the IN route using the MAD.
Interventions
- DRUG Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-11-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02297906
The ClinicalTrials.gov registry entry for NCT02297906 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketorolac is the first listed.
NCT02297906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02297906 about?
NCT02297906 is a clinical study titled "Pharmacokinetics of Intranasal Ketorolac in Children". Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that is typically given to both adults and children by the intravenous (IV) or intramuscular (IM) route for analgesic purposes. Ketorolac can also be given by the intranasal (IN) route using a mucosal atomization device (MAD). We aim to stu...
What is the current status of trial NCT02297906?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2015-02. Estimated completion is 2017-11-29.
What interventions are being tested in trial NCT02297906?
The interventions under investigation include: Ketorolac (DRUG).
Who is sponsoring clinical trial NCT02297906?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.